26 results
Thumbnail

D1.58 - Pilocarpine in the management of allergic rhinosinusitis; a prospective, placebo-controlled study for a novel use of a cholinergic agent

Thumbnail

D1.68 - Rice allergy: a case report

Thumbnail

D1.59 - Asymptomatic sensitisation to food allergens is common in adults -findings from the PAFA study

Thumbnail

D1.60 - Impact of real-world confounders on the accuracy of an AI model to support the read out of skin prick automated test results

Thumbnail

D1.62 - Improved In-vitro Allergy Diagnostics using a Molecular Composite of Purified Peanut Allergens

Thumbnail

D1.63 - Descriptive Study on the Evolution of Patients Treated with Oral Immunotherapy (OIT) Using Pasteurized Egg White at the Fundación Alcorcón University Hospital

Thumbnail

D1.64 - Severe Food Protein-Induced Enterocolitis Syndrome: A French Multicenter Study of Children Admitted to Critical Care

Thumbnail

D1.65 - Pollen Food Allergy Syndrome in Patients with Quercus ilex Sensitization in the Population of Madrid

Thumbnail

D1.66 - Reactivity, severity and tolerance development in 50 wheat-allergic children across two oral food challenges

Thumbnail

D1.67 - Development and validation of Skin Prick Test solutions for assessing sensitization patterns to edible insects among children sensitized to house dust mite

Thumbnail

D1.69 - Safety in the peach juice food challenge in LTP allergic patients

Thumbnail

D1.70 - No more restrictive diets for LTP allergic patients. The importance of oral food challenge

Thumbnail

D1.71 - Risk Factors for Anaphylaxis in Food-Allergic Children During Oral Food Challenge Tests

Thumbnail

D1.72 - Comparison of the allergenic composition of available SPTs for the diagnosis of sensitization to D. pteronyssinus

Thumbnail

D1.57 - Antigen-specific IgE antibody levels as negative predictors of oral food challenge with cow's milk in children with cow's milk allergy

Thumbnail

D3.419 - Prevalence of physical urticaria hives in patients with systemic mastocytosis and their relation to disease course – preliminary data

Thumbnail

D3.411 - Targeting MRGPRX2 for the Treatment of Mast Cell-Driven Diseases

Thumbnail

D3.412 - MRGPRX2 Specific Activation Signature is Enriched in Atopic Dermatitis Lesions and Wheals from Chronic Spontaneous Urticaria Compared to Adjacent Healthy Skin

Thumbnail

D3.413 - Development of the Mastocytosis Symptom Severity Daily Diary (MS2D2) for Non-Advanced Systemic Mastocytosis (NonAdvSM) Patients and Establishing Content Validity

Thumbnail

D3.414 - The Phase 2/3 Study of Elenestinib, a Highly Potent and Selective Tyrosine Kinase Inhibitor, in Patients With Indolent Systemic Mastocytosis